The Media Line Stands Out

Fighting The War of Words

As a teaching news agency, it's about facts first,
stories with context, always sourced, fair,
inclusive of all narratives.

We don't advocate!
Our stories don’t opinionate!

Just journalism done right.
Wishing those celebrating a Happy Passover.

Please support the Trusted Mideast News Source
Donate
The Media Line
Donate
Light Theme
Log In

US pharma company says arthritis drug speeds COVID-19 recovery

The Media Line Staff
09/14/2020
American pharmaceutical company Eli Lilly and Co. on Monday said that its rheumatoid arthritis drug baricitinib, branded as Olumiant, shortens the recovery time for COVID-19 patients when combined with Gilead Sciences’ antiviral remdesivir. The trial, which tested 1,000 patients, showed a roughly one-day reduction in recovery time versus just taking remdesivir.

NEXT FROM
Top Stories
MORE FROM Top Stories
TheMediaLine
WHAT WOULD YOU GIVE TO CHANGE THE MISINFORMATION
about the
ISRAEL-HAMAS WAR?
Time Money Both
Support Us
NEXT FROM
MORE FROM
Personalize Your News
Upgrade your experience by choosing the categories that matter most to you.
Click on the icon to add the category to your Personalize news
Browse Categories and Topics
Life Lines
Student Journalism
People & Pods